AVANIR PHARMACEUTICALS, INC. 3 SEC Filings

Filed On	Filing
03 Apr 2014	Form 3: Corrigan Mark, Director No securities owned
12 Mar 2013	Form 3: Nevinny Corinne H, Director No securities owned
15 May 2012	Form 3: Bishop Hans Edgar, Director No securities owned
26 Mar 2012	Form 3: Palekar Rohan, SVP & Chief Commercial Officer No securities owned
18 Nov 2011	Form 3: Siffert Joao Md, SVP, R&D
21 Apr 2011	Form 3: Sibold William John, SVP & Chief Commercial Ofc No securities owned
03 Aug 2009	Form 3: Vivo Ventures Fund VI, L.p., 10% owner and 1 other Holds 8,743,169 shares of Common Stock
07 Aug 2008	Form 3: Moorin Jay, 10% owner and 1 other Holds 7,820,470 shares of Class A Common Stock
11 Apr 2008	Form 3: Clarus Lifesciences I, L.p., 10% owner and 8 others Holds 15,557,318 shares of Class A Common Stock
29 Feb 2008	Form 3: Ocampo Christine, Vice President, Finance Holds 57,500 shares of Class A Common Stock
21 Feb 2007	Form 3: Sturgeon Martin J, VP, Chief Accounting Officer Holds 10,000 shares of Class A Common Stock
28 Aug 2006	Form 3: Hopereese Theresa, VP, Human Resources
12 May 2006	Form 3: Puntoriero Michael J, Senior VP, Finance Holds 625 shares of Class A Common Stock
21 Feb 2006	Form 3: Orbimed Advisors Llc, Director and 2 others
26 Jan 2006	Form 3: Kaye Randall, VP of Medical Affairs Holds 1,250 shares of Class A Common Stock
18 Nov 2005	Form 3: Whitcup Scott M, Director
06 Oct 2005	Form 3: Wheeler Craig A, Director
15 Sep 2005	Form 3: Brandt Eric, Director Holds 1,000,000 shares of Class A Common Stock
02 Aug 2005	Form 3: Mazzo David J, Director
11 Jul 2005	Form 3: Katkin Keith, Sr. V.P. of Sales & Marketing

Comments